Together, these results demonstrate that ME treatment repressed the chemoresistance of ovarian cancer cells by attenuating the HSP90AB1/IGF1R signaling pathway and allowing cisplatin to induce DNA damage. The gene discussed is IGF1R; the disease is ovarian cancer.